| 产品名称： | Recombinant Adeno-associated virus 2 |
|---|---|
| 商品货号： | TS204623 |
| Classification： | Parvoviridae, Dependovirus, Adeno-associated virus-2 |
| Agent： | Recombinant Adeno-associated virus 2 |
| Strain： | Recombinant Adeno-associated Virus 2 Reference Standard Stock (rAAV2 RSS) |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Comments： | For additional information on handling the Recombinant Adeno-associated Virus 2 Reference Standard Stock,xa0view the AAVRSWG Handling Guidexa0located on the ATCC website at www.atcc.org. |
| Growth Conditions： | Temperature: 37°C |
| Name of Depositor： | Adeno-associated Virus Reference Standard Working Group (AAVRSWG) |
| References： | Moullier P, Snyder, RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol. Ther. 16:1185-1188, 2008. Potter M, et al. Manufacture and stability study of the recombinant adeno-associated virus serotype 2 vector reference standard. BioProcessing Journal 7:8-14, 2008. Burger C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Molecular Therapy : 10(2):302-17, 2004 PubMed: 15294177 Flotte TR, e al. Utility of a recombinant adeno-associated viral vector reference standard. BioProcessing J. 1: 75, 2002. Chadeuf G, et al. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. J. Gene Med. 2(4):260-268, 2000. PubMed: 10953917. Grimm D, et al. Novel tools for production and purification of recombinant adeno-associated virus vectors. Human Gene Therapy 9: 2745-2760, 1998. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Recombinant Adeno-associated virus 2 |
|---|---|
| 商品货号： | TS204623 |
| Classification： | Parvoviridae, Dependovirus, Adeno-associated virus-2 |
| Agent： | Recombinant Adeno-associated virus 2 |
| Strain： | Recombinant Adeno-associated Virus 2 Reference Standard Stock (rAAV2 RSS) |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Comments： | For additional information on handling the Recombinant Adeno-associated Virus 2 Reference Standard Stock,xa0view the AAVRSWG Handling Guidexa0located on the ATCC website at www.atcc.org. |
| Growth Conditions： | Temperature: 37°C |
| Name of Depositor： | Adeno-associated Virus Reference Standard Working Group (AAVRSWG) |
| References： | Moullier P, Snyder, RO. International efforts for recombinant adeno-associated viral vector reference standards. Mol. Ther. 16:1185-1188, 2008. Potter M, et al. Manufacture and stability study of the recombinant adeno-associated virus serotype 2 vector reference standard. BioProcessing Journal 7:8-14, 2008. Burger C. et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Molecular Therapy : 10(2):302-17, 2004 PubMed: 15294177 Flotte TR, e al. Utility of a recombinant adeno-associated viral vector reference standard. BioProcessing J. 1: 75, 2002. Chadeuf G, et al. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. J. Gene Med. 2(4):260-268, 2000. PubMed: 10953917. Grimm D, et al. Novel tools for production and purification of recombinant adeno-associated virus vectors. Human Gene Therapy 9: 2745-2760, 1998. |
